196 related articles for article (PubMed ID: 26980696)
21. Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling.
Lee HH; Park SA; Almazari I; Kim EH; Na HK; Surh YJ
Arch Biochem Biophys; 2010 Sep; 501(1):142-50. PubMed ID: 20558128
[TBL] [Abstract][Full Text] [Related]
22. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1.
Nguyen T; Sherratt PJ; Nioi P; Yang CS; Pickett CB
J Biol Chem; 2005 Sep; 280(37):32485-92. PubMed ID: 16000310
[TBL] [Abstract][Full Text] [Related]
24. Zinc finger E-box-binding homeobox 1 mediates aerobic glycolysis
Xu WY; Hu QS; Qin Y; Zhang B; Liu WS; Ni QX; Xu J; Yu XJ
World J Gastroenterol; 2018 Nov; 24(43):4893-4905. PubMed ID: 30487699
[TBL] [Abstract][Full Text] [Related]
25. Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element.
Chowdhury I; Mo Y; Gao L; Kazi A; Fisher AB; Feinstein SI
Free Radic Biol Med; 2009 Jan; 46(2):146-53. PubMed ID: 18973804
[TBL] [Abstract][Full Text] [Related]
26. UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis.
Abu-Alainin W; Gana T; Liloglou T; Olayanju A; Barrera LN; Ferguson R; Campbell F; Andrews T; Goldring C; Kitteringham N; Park BK; Nedjadi T; Schmid MC; Slupsky JR; Greenhalf W; Neoptolemos JP; Costello E
J Pathol; 2016 Feb; 238(3):423-33. PubMed ID: 26497117
[TBL] [Abstract][Full Text] [Related]
27. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound.
Ohnuma T; Nakayama S; Anan E; Nishiyama T; Ogura K; Hiratsuka A
Toxicol Appl Pharmacol; 2010 Apr; 244(1):27-36. PubMed ID: 20026152
[TBL] [Abstract][Full Text] [Related]
28. An epigenetic regulator: methyl-CpG-binding domain protein 1 (MBD1).
Li L; Chen BF; Chan WY
Int J Mol Sci; 2015 Mar; 16(3):5125-40. PubMed ID: 25751725
[TBL] [Abstract][Full Text] [Related]
29. RNA interference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticles.
Luo G; Jin C; Long J; Fu D; Yang F; Xu J; Yu X; Chen W; Ni Q
Cancer Biol Ther; 2009 Apr; 8(7):594-8. PubMed ID: 19276660
[TBL] [Abstract][Full Text] [Related]
30. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
Itoh K; Mimura J; Yamamoto M
Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
[TBL] [Abstract][Full Text] [Related]
31. Upregulating Nrf2-dependent antioxidant defenses in Pacific oysters Crassostrea gigas: Investigating the Nrf2/Keap1 pathway in bivalves.
Danielli NM; Trevisan R; Mello DF; Fischer K; Deconto VS; da Silva Acosta D; Bianchini A; Bainy AC; Dafre AL
Comp Biochem Physiol C Toxicol Pharmacol; 2017 May; 195():16-26. PubMed ID: 28216009
[TBL] [Abstract][Full Text] [Related]
32. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
33. Keap1 knockdown in melanocytes induces cell proliferation and survival via HO-1-associated β-catenin signaling.
Kim JY; Lee H; Lee EJ; Kim M; Kim TG; Kim HP; Oh SH
J Dermatol Sci; 2017 Oct; 88(1):85-95. PubMed ID: 28583303
[TBL] [Abstract][Full Text] [Related]
34. Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.
Lister A; Nedjadi T; Kitteringham NR; Campbell F; Costello E; Lloyd B; Copple IM; Williams S; Owen A; Neoptolemos JP; Goldring CE; Park BK
Mol Cancer; 2011 Apr; 10():37. PubMed ID: 21489257
[TBL] [Abstract][Full Text] [Related]
35. [Activation of multiple tumor suppressor genes by MBD1 siRNA in pancreatic cancer cell line BxPC-3].
Xu J; Liu C; Yu XJ; Jin C; Fu DL; Ni QX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1948-51. PubMed ID: 19062732
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathy.
Mishra M; Zhong Q; Kowluru RA
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7256-65. PubMed ID: 25301875
[TBL] [Abstract][Full Text] [Related]
37. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway.
Yu M; Li H; Liu Q; Liu F; Tang L; Li C; Yuan Y; Zhan Y; Xu W; Li W; Chen H; Ge C; Wang J; Yang X
Cell Signal; 2011 May; 23(5):883-92. PubMed ID: 21262351
[TBL] [Abstract][Full Text] [Related]
38. NRF2-Driven
Tian Y; Liu Q; Yu S; Chu Q; Chen Y; Wu K; Wang L
Mol Cancer Res; 2020 Oct; 18(10):1465-1476. PubMed ID: 32571982
[TBL] [Abstract][Full Text] [Related]
39. Drug screening assay based on the interaction of intact Keap1 and Nrf2 proteins in cancer cells.
Zhou B; Zhang X; Wang G; Barbour KW; Berger FG; Wang Q
Bioorg Med Chem; 2019 Jan; 27(1):92-99. PubMed ID: 30473361
[TBL] [Abstract][Full Text] [Related]
40. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
Chen CS; Tseng YT; Hsu YY; Lo YC
Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
